or
Bookmark and Share
   
Document Number
US Patent 5578610
Issued Date
November 26, 1996
Link
Inventors
Map
Abstract
The present invention relates to substantially pure piperidine derivative compounds of the formulae: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; R.sub.3 is --COOH or --COOR.sub.4 ; R.sub.4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.
Drawing
Piperidine derivatives - US Patent 5578610 Drawing
Drawing from US Patent 5578610
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
17
Comments:
no comments yet
Owner
Published
November 26, 1996
Application Number
08/456,273
Filed
May 31, 1995
US Classification
514/317   546/239
Int'l Classification
C07D   211/32   (20060101)   C07D   211/22   (20060101)   C07D   211/00   (20060101)   C07C   59/00   (20060101)   C07C   69/00   (20060101)   C07C   59/86   (20060101)   C07C   69/738   (20060101)  
Examiner
Assistant Examiner
Parent Case
This is a division of U.S. application Ser. No. 08/382,649, filed Feb. 2, 1995, which is a continuation of U.S. application Ser. No. 08/083,102, filed Jun. 24, 1993 abandoned.
USPTO Field of Search
514/317   541/239  
Related Patents
6613906 - Crystal modification - Owned by Geneva Pharmaceuticals, Inc. (Broomfield, CO)

A novel crystal form of ,.alpha.-dimethyl-4-{1-hydroxy-4-{4-(hydroxydiphenylmethyl)-1-piperidinyl} butyl}benzeneacetic acid hydrochloride, processes for its preparation and its pharmaceutical use are disclosed.

6509353 - Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors - Owned by Sepracor Inc. (Marlborough, MA)

Methods and pharmaceutical compositions employing a terfenadine metabolite and a leukotriene inhibitor for the treatment or prevention of inflammation or allergic disorders, such as asthma, or symptoms thereof. Also included are methods and compositions employing a terfenadine metabolite, a leukotriene inhibitor, and a decongestant for the treatment or prevention of inflammation or allergic disorders, such as asthma, or symptoms thereof.

7135571 - Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof - Owned by Aventis Pharmaceuticals, Inc. (Bridgewater, NJ)

The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas ##STR00001## which are useful as antihistamines, antiallergic agents and bronchodilators.

7138524 - Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof - Owned by Aventis Pharmaceuticals, Inc. (Bridgewater, NJ)

The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas ##STR00001## which are useful as antihistamines, antiallergic agents and bronchodilators.

7390906 - Piperidine derivatives and process for their production - Owned by AMR Technology, Inc. (Manchester, VT)

The present invention relates to substantially pure piperidine derivative compounds of the formulae: ##STR00001## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2; R.sub.3 is --COOH or --COOR.sub.4; R.sub.4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us